Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-909.87%
operating margin TTM
-950.92%
revenue TTM
N/A
revenue per share TTM
0.0$
valuation ratios | |
|---|---|
| pe ratio | -0.44 |
| peg ratio | -0.02 |
| price to book ratio | 0.20 |
| price to sales ratio | 2.08 |
| enterprise value multiple | -0.38 |
| price fair value | 0.20 |
profitability ratios | |
|---|---|
| gross profit margin | 61.41% |
| operating profit margin | -950.92% |
| pretax profit margin | -958.29% |
| net profit margin | -909.87% |
| return on assets | -25.56% |
| return on equity | -52.54% |
| return on capital employed | -36.7% |
liquidity ratios | |
|---|---|
| current ratio | 0.99 |
| quick ratio | 0.40 |
| cash ratio | 0.20 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 5,429.06 |
| operating cycle | 5,803.78 |
| days of payables outstanding | 2,643.01 |
| cash conversion cycle | 3,160.77 |
| receivables turnover | 0.97 |
| payables turnover | 0.14 |
| inventory turnover | 0.07 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.01 |
| debt equity ratio | 0.02 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.02 |
| interest coverage | -88.60 |
| cash flow to debt ratio | -19.04 |
cash flow ratios | |
|---|---|
| free cash flow per share | -1.62 |
| cash per share | 0.36 |
| operating cash flow per share | -1.62 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -19.04 |
| short term coverage ratios | -34.84 |
| capital expenditure coverage ratio | 0.00 |
Frequently Asked Questions
When was the last time Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) reported earnings?
Citius Pharmaceuticals, Inc. (CTXR) published its most recent earnings results on 13-02-2026.
What is Citius Pharmaceuticals, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Citius Pharmaceuticals, Inc. (NASDAQ:CTXR)'s trailing twelve months ROE is -52.54%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Citius Pharmaceuticals, Inc. (CTXR) currently has a ROA of -25.56%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did CTXR's net profit margin stand at?
CTXR reported a profit margin of -909.87% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is CTXR's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 0.99 in the most recent quarter. The quick ratio stood at 0.40, with a Debt/Eq ratio of 0.02.